The Impact of Adjuvant Postoperative Radiation Therapy and Chemotherapy on Survival After Esophagectomy for Esophageal Carcinoma

被引:52
|
作者
Wong, Andrew T. [1 ,2 ]
Shao, Meng [1 ,2 ]
Rineer, Justin [3 ]
Lee, Anna [1 ,2 ]
Schwartz, David [1 ,2 ]
Schreiber, David [1 ,2 ]
机构
[1] Dept Vet Affairs New York Harbor Healthcare Syst, Dept Radiat Oncol, Brooklyn, NY USA
[2] Suny Downstate Med Ctr, Dept Radiat Oncol, 450 Clarkson Ave,Box 1211, Brooklyn, NY 11203 USA
[3] UF Hlth Canc Ctr Orlando Hlth, Dept Radiat Oncol, Orlando, FL USA
关键词
chemotherapy; esophageal cancer; esophagectomy; radiation therapy; SQUAMOUS-CELL CARCINOMA; THORACIC ESOPHAGUS; RANDOMIZED TRIAL; RADIOTHERAPY; SURGERY; CANCER; CHEMORADIOTHERAPY; RESECTION;
D O I
10.1097/SLA.0000000000001825
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: The objective of this study was to analyze the impact on overall survival (OS) from the addition of postoperative radiation with or without chemotherapy after esophagectomy, using a large, hospital-based dataset. Background: Previous retrospective studies have suggested an OS advantage for postoperative chemoradiation over surgery alone, although prospective data are lacking. Methods: The National Cancer Data Base was queried to select patients diagnosed with stage pT3-4Nx-0M0 or pT1-4N1-3M0 esophageal carcinoma (squamous cell or adenocarcinoma) from 1998 to 2011 treated with definitive esophagectomy +/- postoperative radiation and/or chemotherapy. OS was analyzed using the Kaplan-Meier method and compared using the log-rank test. Multivariate Cox regression analysis was used to identify covariates associated with OS. Results: There were 4893 patients selected, of whom 1153 (23.6%) received postoperative radiation. Most patients receiving radiation also received sequential/concomitant chemotherapy (89.9%). For the entire cohort, postoperative radiation was associated with a statistically significant but modest absolute improvement in survival (hazard ratio 0.77; 95% CI, 0.71-0.83; P < 0.001). On subgroup analysis, postoperative radiation was associated with improved OS for patients with node-positive disease (3-yr OS 34.3 % vs 27.8%, P < 0.001) or positive margins (3-yr OS 36.4% vs 18.0%, P < 0.001). When chemotherapy usage was incorporated, sequential chemotherapy was associated with the best survival (P < 0.001). Multivariate analysis revealed that the addition of chemotherapy to radiation therapy, whether sequentially or concurrently, was a strong prognostic factor for OS. Conclusions: In this hospital-based study, the addition of postoperative chemoradiation (either sequentially or concomitantly) after esophagectomy was associated with improved OS for patients with node-positive disease or positive margins.
引用
收藏
页码:1146 / 1151
页数:6
相关论文
共 50 条
  • [21] Adjuvant chemotherapy and outcomes in esophageal carcinoma
    Saeed, Nadia A.
    Mellon, Eric A.
    Meredith, Kenneth L.
    Hoffe, Sarah E.
    Shridhar, Ravi
    Frakes, Jessica
    Fontaine, Jacque-Pierre
    Pimiento, Jose M.
    Kothari, Nishi
    Almhanna, Khaldoun
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2017, 8 (05) : 816 - 824
  • [22] Combined modality therapy for patients with esophageal squamous cell carcinoma: Radiation dose and survival analyses
    Shueng, Pei-Wei
    Huang, Chun-Chieh
    Liu, Yu-Ming
    Wu, Yuan-Hong
    Huang, Pin-, I
    Yen, Sang-Hue
    Lin, Kuan-Heng
    Hsu, Chen-Xiong
    THORACIC CANCER, 2023, 14 (02) : 143 - 148
  • [23] Survival Comparison Among Neoadjuvant Chemoradiotherapy Followed by Esophagectomy, Definitive Chemoradiotherapy, and Esophagectomy Alone for Esophageal Squamous Cell Carcinoma
    Chen, Hui-Shan
    Lin, Ching-Hsiung
    Wu, Shiao-Chi
    Wang, Bing-Yen
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (06) : 3617 - 3627
  • [24] Impact of Tumor Size on Survival Outcome in Esophageal Squamous Cell Carcinoma After Esophagectomy Following Neoadjuvant Chemotherapy
    Koterazawa, Yasufumi
    Oshikiri, Taro
    Goto, Hironobu
    Kato, Takashi
    Sawada, Ryuichiro
    Harada, Hitoshi
    Urakawa, Naoki
    Hasegawa, Hiroshi
    Kanaji, Shingo
    Yamashita, Kimihiro
    Matsuda, Takeru
    Kakeji, Yoshihiro
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (04) : 2482 - 2489
  • [25] Esophagectomy Versus Endoscopic Resection with Adjuvant Therapy for T1b/T2 Esophageal Cancer: A Systematic Review and Meta-Analysis
    Peters, Eagan J.
    Robinson, Madeline
    Patel, Noopur
    Kidane, Biniam
    CANCERS, 2025, 17 (04)
  • [26] Post-esophagectomy Adjuvant Chemotherapy Benefits Esophageal Cancer Patients
    Sohda, Makoto
    Saito, Hideyuki
    Kuriyama, Kengo
    Yoshida, Tomonori
    Kumakura, Yuji
    Honjyo, Hiroaki
    Hara, Keigo
    Ozawa, Daigo
    Suzuki, Shigemasa
    Tanaka, Naritaka
    Sakai, Makoto
    Miyazaki, Tatsuya
    Fukuchi, Minoru
    Kuwano, Hiroyuki
    IN VIVO, 2019, 33 (02): : 501 - 506
  • [27] Feasibility study of adjuvant chemotherapy with S-1 after curative esophagectomy following neoadjuvant chemotherapy for esophageal cancer
    Hirahara, Noriyuki
    Matsubara, Takeshi
    Kaji, Shunsuke
    Hayashi, Hikota
    Kawakami, Koki
    Sasaki, Yohei
    Takao, Satoshi
    Takao, Natsuko
    Hyakudomi, Ryoji
    Yamamoto, Tetsu
    Tajima, Yoshitsugu
    BMC CANCER, 2022, 22 (01)
  • [28] Postoperative Radiation Therapy After Complete Resection of Thymoma Has Little Impact on Survival
    Utsumi, Tomoki
    Shiono, Hiroyuki
    Kadota, Yoshihisa
    Matsumura, Akihide
    Maeda, Hajime
    Ohta, Mitsunori
    Yoshioka, Yasuo
    Koizumi, Masahiko
    Inoue, Takehiro
    Okumura, Meinoshin
    CANCER, 2009, 115 (23) : 5413 - 5420
  • [29] Propensity score analysis comparing survival between definitive chemoradiotherapy and esophagectomy with adjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
    Chang, Yi-Lin
    Cheng, Ya-Fu
    Chen, Hui-Shan
    Wu, Siao-Chi
    Hung, Wei-Heng
    Chen, Heng-Chung
    Huang, Chang-Lun
    Cheng, Ching-Yuan
    Wang, Bing-Yen
    PLOS ONE, 2022, 17 (10):
  • [30] High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma
    Lertbutsayanukul, Chawalit
    Tharavej, Chadin
    Klaikeaw, Naruemon
    Prayongrat, Anussara
    Lowanitchai, Chutinan
    Sriuranpong, Virote
    THORACIC CANCER, 2017, 8 (03) : 219 - 228